Skip to content

American Tissue Corp.

American Tissue Corp. was a US tissue-paper and paper-products manufacturer that collapsed in a high-profile accounting fraud in the early 2000s.

Last updated October 30, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

American Tissue Corp. was a United States-based manufacturer of tissue paper and related consumer paper products, operating mills that converted pulp into bathroom tissue, paper towels, napkins and similar household and commercial paper goods. It grew through the acquisition of paper mills and built a position as a low-cost producer of private-label and commodity tissue products sold to retailers and distributors. The company is chiefly remembered not for its brands but for its collapse. In the early 2000s American Tissue filed for bankruptcy protection amid allegations that its management had inflated revenues and assets through fictitious sales and accounting irregularities, a case that became a notable example of corporate fraud in the paper industry. Its mills and assets were subsequently sold off or taken over by other paper producers, and the corporate entity ceased to operate as an independent business. Because the company operated largely as a contract and private-label manufacturer, it had limited consumer-facing brand recognition; its identity rested on its mill network and its role as a supplier rather than on trademarked consumer products. The supplied evidence does not contain verifiable material about American Tissue Corp.; the snippets provided concern unrelated technology and media subjects and were not used for factual claims.

History

American Tissue Corp. emerged as a US paper manufacturer that assembled a network of tissue and paper mills, positioning itself as a low-cost supplier of tissue paper and private-label household and commercial paper products. Its business model depended on acquiring and running converting and papermaking facilities and selling volume output to retailers, distributors and institutional customers rather than building heavily advertised consumer brands. In the early 2000s the company entered bankruptcy proceedings, and the case became widely cited for accounting fraud: allegations centered on inflated revenues and assets, including fictitious sales, which undermined the company's reported financial position. The bankruptcy and subsequent investigations led to the breakup and sale of its mills and assets to other paper producers, and American Tissue Corp. ceased to exist as an independent operating company. No reliable, verifiable details on founding date, founders, headquarters location, ownership structure or specific mill sites are available in the supplied evidence, and those fields are therefore left blank rather than guessed. The evidence snippets provided concern unrelated technology and media topics and contain no information about this company.

Products and positioning

Low-cost, mill-based producer of tissue and private-label paper products rather than a consumer brand marketer.

  • Tissue paper and converted paper products

    Mill-produced bathroom tissue, towels and napkins sold largely as private-label and commodity paper goods.

Controversies

  • 2026

    Greater Augusta Utility District sues paper companies over PFAS contamination of Augusta-area drinking-water wells

    The Greater Augusta Utility District, which supplies drinking water to about 13,750 residents in and around Augusta, Maine, filed a federal lawsuit against Sappi North America, Huhtamaki, Kimberly-Clark, American Tissue Mills of Maine and American Tissue Corp. The district alleges that PFAS released over decades from the companies' paper, packaging and tissue facilities entered the Kennebec River and connected groundwater and contaminated the wells serving the Augusta area. The district alleges PFAS was detected in its well water in October 2021 and rose above Maine's drinking-water standard in November 2024, and it seeks to hold the companies jointly and severally liable under the federal Superfund law (CERCLA) for past and future investigation, monitoring, treatment and cleanup costs. Sappi said it is reviewing the complaint, stating it complies with all environmental regulations and does not knowingly use PFAS-containing materials; the other named companies did not respond to comment requests.

Read more

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/american-tissue-corp · Editorial policy · How profiles are compiled